Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, David R. Raleigh, Michael V. Martin et al.|Nature Genetics|2022Cited by 296
Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approachStephen T. Magill, Michael W. McDermott, Ramin A. Morshed et al.|Neurosurgical FOCUS|2018Cited by 118
Meningioma metastases: incidence and proposed screening paradigmCecilia L. Dalle Ore, Michael McDermott, Stephen T. Magill et al.|Journal of neurosurgery|2019Cited by 97
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresAbrar Choudhury, David R. Raleigh, William Chen et al.|Neuro-Oncology|2022Cited by 69
Surgical outcomes after reoperation for recurrent skull base meningiomasStephen T. Magill, Michael McDermott, David S. Lee et al.|Journal of neurosurgery|2018Cited by 65